Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal

Endocrinology

Volumn 150, Issue 7, 2009, Pages 3118-3127

  Núñez, Cristina ^a   Földes, Anna ^b   Pérez Flores, Domingo ^a   García Borrón, J Carlos ^a   Laorden, M Luisa ^a   Kovács, Krisztina J ^b   Milanés, M Victoria ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOSTERONE; GLUCOCORTICOID; MESSENGER RNA; MORPHINE; SERINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DRUG DEPENDENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HORMONE RELEASE; IMMUNOREACTIVITY; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CORTICOSTERONE; HYDROCORTISONE; MALE; MORPHINE; MORPHINE DEPENDENCE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHOSPHORYLATION; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE; WEIGHT LOSS;

EID: 67649665609     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1732     Document Type: Article

References (51)

1. Koob GF, Le Moal M 2008 Addiction and the brain antireward system. Annu Rev Psychol 59:29-53
2. Le Moal M, Koob GF 2007 Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol 17:377-393 (Pubitemid 46497657)
3. Sinha R 2007 The role of stress in addiction relapse. Curr Psychiatry Rep 9:388-395 (Pubitemid 47559360)
4. Koob GF, Le Moal M 2001 Drug addiction, dysregulation of reward and allostasis. Neuropsychopharmacology 24:97-129
5. Contarino A, Papaleo F 2005 The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opioid withdrawal. Proc Natl Acad Sci USA 102:18649-18654 (Pubitemid 43011280)
6. Koob G, Kreek MJ 2007 Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-1159 (Pubitemid 47292402)
7. Cleck JN, Blendy JA 2008 Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest 118:454-461 (Pubitemid 351206533)
8. Laorden ML, Núñez C, Almela P, Milanés MV 2002 Morphine withdrawalinduced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J Neurochem 83: 132-140
9. Núñez C, Földes A, Laorden ML, Milanes MV, Kovacs KJ 2007 Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem 101:1060-1071
10. 2-adrenoceptors. J Pharmacol Exp Ther 293:578-584
11. Fuertes G, Laorden ML, Milanés MV 2000 Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 71:60-67 (Pubitemid 30045336)
12. Haycock JW 1993 Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40. Neurochem Res 18:15-26
13. Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW 2004 Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025-1043 (Pubitemid 39587442)
14. Núñez C, Laorden ML, Milanés MV 2007 Regulation of serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group: role of ERK1/2. Endocrinology 148:5780-5793 (Pubitemid 350146166)
15. Deroche-Gamonet V, Sillaber I, Aouizerate B, Izawa R, Jaber M, Ghozland S, Kellendonk C, Le Moal M, Spanagel R, Schütz G, Tronche F, Piazza PV 2003 The glucocorticoid receptor as a potential target to reduce cocaine abuse. J Neurosci 23:4785-4790 (Pubitemid 36706207)
16. Shalev U, Marinelli M, Baumann M, Piazza PV, Shaham Y 2003 The role of corticosterone in food deprivation-induced reinstatement of cocaine seeking in the rat. Psychopharmacology 168:170-176 (Pubitemid 36851176)
17. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, CullinanWE2003 Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24:151-180 (Pubitemid 37336539)
18. Cunningham Jr ET, Sawchenko PE 1988 Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274:60-76 (Pubitemid 18187902)
19. Rusnaá M, Kvetnanský R, Jeloková J, PalkovitsM2001 Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats. Brain Res 899:20-35 (Pubitemid 32324144)
20. Pacak K, Palkovits M, Kopin IJ, Goldstein DS 1995 Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitaryadrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front Neuroendocrinol 16:89-150
21. Plotsky PM 1987 Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121:924-930 (Pubitemid 17139142)
22. Kovács KJ, Földes A, Sawchenko PE 2000 Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 20:3843-3852 (Pubitemid 30266245)
23. Bhargava HN, Gulati A, Ramarao P 1989 Effects of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J Pharmacol Exp Ther 251: 21-26 (Pubitemid 19261941)
24. Palkovits M, Brownstein MJ 1988 Maps and guide to microdissection of the rat brain. New York: Elsevier
25. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates. 4th ed. San Diego: Academic Press
26. Houshyar H, Manalo S, Dallman MF 2004 Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo- pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci 24:9414-9424 (Pubitemid 39426177)
27. Germano CM, de Castro M, Rorato R, Laguna MT, Antunes-Rodrigues J, Elias CF, Elias LL 2007 Time course effects of adrenalectomy and food intake on cocaine- and amphetamine-regulated transcript expression in the hypothalamus. Brain Res 1166:55-64 (Pubitemid 47268304)
28. Margules DL 1979 The obesity of middle age: a common variety of Cushing's syndrome due to a chronic increase in adrenocorticotrophin (ACTH) and β-endorphin activity. Adv Exp Med Biol 116:279-290
29. Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ 2003 Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes 52:2928-2934 (Pubitemid 37466862)
30. Kovács GL, Telegdy G 1988 Hypothalamo-neurohypophyseal neuropeptides and experimental drug addiction. Brain Res Bull 20:893-895 (Pubitemid 19266481)
31. Koob GF, Moal ML 1997 Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58 (Pubitemid 27446270)
32. Maldonado R 1997 Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 1:91-104 (Pubitemid 27044553)
33. Aston-Jones G, Delfs JM, Druhan J, Zhu Y 1999 The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann NY Acad Sci 877:486-498
34. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G 2000 Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434 (Pubitemid 30073092)
35. Wong DL, Tank AW 2007 Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress 10:121-130 (Pubitemid 46789481)
36. Kumer SC, Vrana KE 1996 Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443-462 (Pubitemid 26255637)
37. Hagerty T, Fernandez E, Lynch K, Wang SS, Morgan WW, Strong R 2001 Interaction of a glucocorticoid-responsive element with regulatory sequences in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 78:1379-1388 (Pubitemid 32899769)
38. Stachowiak MK, Rigual RJ, Lee PH, Viveros OH, Hong JS 1988 Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferasemRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Res 427:275-286 (Pubitemid 18148323)
39. Fuxe K, Cintra A, Härfstrand A, Agnati LF, Kalia M, Zoli M, Wikström AC, Okret S, Aronsson M, Gustafsson JA 1987 Central glucocorticoid receptor immunoreactive neurons: new insights into the endocrine regulation of the brain. Ann NY Acad Sci 512:362-393 (Pubitemid 18132454)
40. Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL 2006 Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138:901-910 (Pubitemid 43306830)
41. Izawa R, Jaber M, Deroche-Gamonet V, Sillaber I, Kellendonk C, Le Moal M, Tronche F, Piazza PV 2006 Gene expression regulation following behavioral sensitization to cocaine in transgenic mice lacking the glucocorticoid receptor in the brain. Neuroscience 137:915-924 (Pubitemid 43053954)
42. Smith MA, Brady LS, Glowa J, Gold PW, Herkenham M 1991 Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res 544:26-32
43. Makino S, Smith MA, Gold PW 2002 Regulatory role of glucocorticoids and glucocorticoid receptormRNAlevels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res 943: 216-223 (Pubitemid 36120381)
44. Chappell PB, SmithMA,KiltsCD,Bissette G, Ritchie J, Anderson C, Nemeroff CB 1986 Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914 (Pubitemid 16026071)
45. Meli KR, Duman RS 1991 Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 88:8382-8386 (Pubitemid 21915360)
46. Curtis AL, Grigoriadis DE, Page ME, Rivier J, Valentino RJ 1994 Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies. J Pharmacol Exp Ther 268:359-365 (Pubitemid 24039109)
47. McDonald TJ, Le WW, Hoffman GE 2000 Brainstem catecholaminergic neurons activated by hypoxemia express GR and are coordinately activated with fetal sheep hypothalamic paraventricularCRHneurons. Brain Res 885:70-78 (Pubitemid 30833940)
48. Boundy VA, Gold SJ, Messer CJ, Chen J, Son JH, Joh TH, Nestler EJ 1998 Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-lacZ transgenic mice. J Neurosci 18:9989-9995
49. Núñez C, Castells MT, Laorden ML, MilanésMV 2008 Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. Naunyn Schmiedebergs Arch Pharmacol 378:407-420
50. Fürst R, Zahler S, Vollmar AM 2008 Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species. Endocrinology 149:3635-3642 (Pubitemid 351919577)
51. Cote-Vélez A, Pérez-Martínez L, Charli JL, Joseph-Bravo P 2008 The PKC and ERK/MAPK pathways regulate glucocorticoid action on TRH transcription. Neurochem Res 33:1582-1591